ArticleJournal of medicinal chemistry2026

Discovery of ZJC-11 as a Novel Selective CDK7 Inhibitor for Treating Triple-Negative Breast Cancer by Inducing Cell Senescence.

Bo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.